Clinical characteristics and prognosis of ALL in children with CDKN2A/B gene deletion

CDKN2A 医学 白细胞 B组 内科学 存活率 胃肠病学 癌症
作者
Yiyu Wang,Pei‐Ei Wu,Xiaoyan Mao,Nanjing Jiang,Yu Huang,Li Zhang,Li Liu,Xin Tian
出处
期刊:Experimental Biology and Medicine [SAGE Publishing]
卷期号:250
标识
DOI:10.3389/ebm.2025.10447
摘要

This study aimed to explore the correlation between the deletion of the CDKN2A/B gene and the prognosis of pediatric acute lymphoblastic leukemia (ALL) patients. A total of 310 pediatric patients who were diagnosed with acute lymphoblastic leukemia at our hospital from January 2020 to September 2023 were included in this study. Among them, 78 patients with CDKN2A/B deletion were included in the final analysis. Additionally, 78 ALL patients without CDKN2A/B deletion, who were diagnosed during the same period, were randomly selected for comparison. A statistical analysis was conducted to compare the clinical characteristics and prognosis between the CDKN2A/B deletion group and the non-deletion group in ALL patients. The results showed that pediatric ALL patients with CDKN2A/B deletion had higher white blood cell counts and a greater proportion of immature cells in peripheral blood at diagnosis. The age at diagnosis was older in the deletion group, with a greater proportion in the >10-year-old group. CDKN2A/B deletion occurred more frequently in pediatric patients with T-ALL than in pediatric patients with B-ALL. Patients with CDKN2A/B deletion were more likely to have positive BCR-ABL1 expression combined with IKZF1 deletion. The overall survival (OS) rate was 89.7%, and the event-free survival (EFS) rate was 83.3% in the CDKN2A/B deletion group, which was lower than the OS rate of 97.4% and EFS rate of 93.6% in the non-deletion group. These results suggest that CDKN2A/B deletion may be one of the factors affecting poor prognosis. It provides a new perspective for clinical treatment, risk stratification, and prognostic assessment in pediatric ALL patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
WWW完成签到,获得积分10
刚刚
daidai完成签到,获得积分10
刚刚
好久不见完成签到,获得积分10
刚刚
顺利舟完成签到,获得积分10
刚刚
Wang完成签到,获得积分10
1秒前
等待的汉堡完成签到 ,获得积分10
1秒前
yohohi完成签到,获得积分10
1秒前
十二一字曾完成签到,获得积分10
1秒前
1秒前
与诚完成签到,获得积分10
2秒前
conlensce完成签到,获得积分10
2秒前
蕾蕾发布了新的文献求助10
2秒前
LX完成签到,获得积分10
2秒前
孙丫丫丫丫丫完成签到,获得积分10
3秒前
00gi完成签到,获得积分10
4秒前
Lily完成签到,获得积分10
5秒前
旺旺仙贝完成签到 ,获得积分10
5秒前
Irissun完成签到,获得积分10
5秒前
务实天空完成签到,获得积分10
5秒前
qu蛐完成签到 ,获得积分10
6秒前
Blank完成签到,获得积分10
6秒前
Ss完成签到,获得积分10
6秒前
Hh完成签到,获得积分10
7秒前
斯文败类的应助被简隋英采纳,获得10
7秒前
Lz关注了科研通微信公众号
7秒前
科研狗完成签到,获得积分0
7秒前
Lee完成签到,获得积分10
7秒前
缥缈书竹完成签到,获得积分10
7秒前
qikan编辑完成签到,获得积分10
7秒前
看文献了完成签到,获得积分10
7秒前
剧透了啊啊完成签到,获得积分10
8秒前
刘洋完成签到,获得积分10
8秒前
yy完成签到 ,获得积分10
8秒前
志英完成签到,获得积分10
9秒前
单纯的自行车完成签到,获得积分10
9秒前
科研通AI6.2的应助被然目之绮采纳,获得10
9秒前
9秒前
萌新完成签到,获得积分10
9秒前
831143完成签到 ,获得积分0
9秒前
cc完成签到 ,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159288
求助须知:如何正确求助?哪些是违规求助? 9554702
关于积分的说明 21720900
捐赠科研通 7748911
什么是DOI,文献DOI怎么找? 3427184
关于科研通互助平台的介绍 2552111
邀请新用户注册赠送积分活动 2471479